Prior to joining Turning Point, Erik led the Specialty Division of a diversified healthcare and technology company. Prior to his last engagement, Erik was the vice president of corporate business development for FFF Enterprises a diversified healthcare company. Erik started his career in the pharmaceutical industry where he held leadership roles with Eli Lilly and Merck in the areas of sales, in-line and new product marketing, market access, PBM and Managed Care corporate accounts, strategic planning, and the creation of new distribution models.
Erik is a Board member and member of the Executive Committee of the National Association of Specialty Pharmacy (NASP) and is the acting Secretary of the Board. He is also an editorial board member for Specialty Pharmacy Times.
Erik holds a Bachelor of Science in Business Management from St. John’s University, Minnesota, and a Masters in Business Administration from St. Joseph’s University, Philadelphia.